Unexplained Infertility Treated by Hysteroscopy-laparoscopy

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04465045
Collaborator
(none)
250
1
4
62.4

Study Details

Study Description

Brief Summary

Retrospective study, including patients from january 2013 to december 2018, who were diagnosed with unexplained infertility : spontaneously ovulating women with normal pelvic ultrasound scan, patent tubes on hysterosalpingography and normal pelvic exam or pelvic MRI normal. Semen analyses were normal according to the World Health Organization criteria. Couples were referred for diagnostic laparoscopy and hysteroscopy. They were then addressed for spontaneous fertility or ART to conceive. The investigators would like to see how many surgeries were useful to assess a diagnostic, and if operating allows a satisfying pregnancy rate. The investigators would like to assess how many diagnosis was done after surgery and how many pregnancy were obtained. The investigators search other prognostic factors than age or parity.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Laparoscopy-hysteroscopy

Study Design

Study Type:
Observational
Actual Enrollment :
250 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Unexplained Infertility Treated by Hysteroscopy-laparoscopy : Predictive Factors of Pregnancy
Actual Study Start Date :
Jun 1, 2020
Actual Primary Completion Date :
Sep 30, 2020
Actual Study Completion Date :
Oct 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Unique cohort

All women, 18 to 43 years, operated from laparoscopy-hysteroscopy for unexplained infertility in montpellier university hospital

Procedure: Laparoscopy-hysteroscopy
Under general anesthesia, we start by a first look in laparoscopy, to look for endometriosis mainly, tubal infertility, ovarian cysts or any abnormalities that may not have been suspected on the first exam. Then we check tubal patency after a look at the uterine cavity by hysteroscopy. Then we treat everything possible to treat to improve fertility, spontaneous or with ART.

Outcome Measures

Primary Outcome Measures

  1. clinical pregnancy rate [1 day]

    pregnancy with an hearbeat on a pelvic ultrasound scan

Secondary Outcome Measures

  1. Number of Participants with miscarriage [1 day]

    Number of Participants with miscarriage : positive pregnancy blood test, resulting in bleeding

  2. live birth rate [1 day]

    live birth rate : birth of a viable foetus after 24 SA

  3. Number of Participants with fœtal losses [1 day]

    Number of Participants with Foetal losses : loss of a non viable foetus, before 24 SA

  4. Number of Participants with ectopic pregnancy [1 day]

    Number of Participants with ectopic pregnancy: tubal pregnancy highly suspected by blood test or seen on a pelvic ultrasound scan

  5. Number of Participants with surgical complications [1 day]

    Number of Participants withSurgical complications : during surgery, and a few days after surgery

  6. Number of Participants with type of surgery [1 day]

    Number of Participants with type of surgery: tubal surgeries, adhesiolysis, endometriosis surgeries, hysteroscopic gestures.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 43 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • 18-43y

  • unexplained infertility

  • operated from laparoscopy-hysteroscopy at montpellier university hospital

Exclusion criteria:
  • an IMR that diagnoses formelly an endometriosis, or endometriosic ovarian cysts

  • any non respect to inclusion criterias

  • non respect of our definition of unexplained infertility (such as bilateral tubal issue on hysterosalpingograms)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Uhmontpellier Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Study Director: Claire Vincens, doctor of medecine, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04465045
Other Study ID Numbers:
  • RECHMPL20_0084
First Posted:
Jul 9, 2020
Last Update Posted:
Dec 29, 2020
Last Verified:
Dec 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 29, 2020